#Santé Ailleurs UK Cost deters NICE from Sanofi's bowel cancer drug Zaltrap - PMLiVE http://t.co/tvGpkxn5Sb cc @mtu31 trop cher mon fils
June 24, 2013
/http%3A%2F%2Fwww.pmlive.com%2F__data%2Fassets%2Fimage%2F0005%2F484727%2FSanofi-Zaltrap-aflibercept.jpg)
Cost deters NICE from Sanofi's bowel cancer drug Zaltrap
The UK's National Institute for Health and Care Excellence (NICE) last week determined that the high cost of Sanofi's cancer drug Zaltrap meant it was unsuitable for use on the NHS to treat advanced bowel cancer.